drugset / Trial / NCT07556731

Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia

NCT07556731

Phase 3 Not yet recruiting 100 enrolled Hospital General de Mexico
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to compare ferrous salt and liposomal iron for the treatment of iron-deficiency anemia in adult women. The study will also evaluate how well each treatment is tolerated. The main questions this study aims to answer are: Does liposomal iron increase hemoglobin levels as effectively as ferrous salt? Are there differences in side effects, especially gastrointestinal symptoms, between the treatments? Does dosing ferrous salt every other day improve tolerance compared to daily dosing? Researchers will compare three oral iron treatment strategies to determine which approach provides the best balance between effectiveness and tolerability. Participants will: Be adult women diagnosed with iron-deficiency anemia Be randomly assigned to one of three groups: Daily ferrous salt Ferrous salt taken every other day Daily liposomal iron Take the assigned iron treatment for 3 months Have blood tests at the beginning and end of the study to measure hemoglobin and iron levels Report any side effects or intolerance during treatment

Timeline

Start
2026-05-01
Primary completion
2027-05-01
Completion
2027-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 60 mg
Comparator Liposomal iron Unknown 19.2 mg Oral